Proactive Investors - Run By Investors For Investors

Callitas Health promotes Joshua Maurice to sales VP

Maurice’s promotion comes as the clinical-stage pharmaceutical development group advances its programs and partnerships
desk
Callitas Health is developing innovative remedies for weight management, female sexual health, cannabis delivery and other proprietary drugs

Callitas Health Inc (CSE:LILY) (OTCQB:MPHMF) said Tuesday that Joshua Maurice has been promoted to vice-president of sales and business development.

Maurice’s promotion comes as the clinical-stage pharmaceutical development group adds to its management and hires consultants to advance its programs and partnerships and build on this year’s progress.

READ: Callitas Health banks on CannaStrips and OTC products while swinging for the fence with blockbuster drugs

“We’ve seen important strides in the first months of 2019 across the women’s health, cannabinoid and infertility spaces and deepening partnerships with companies like NFI Consumer Healthcare and Lifestyles,” said James Thompson, CEO of Callitas, in a statement.

“Promoting Joshua to this new position allows us to utilize his talents to further capitalize on these advancements in the company,” he added.

Formed in early 2015, Callitas Health is developing innovative remedies for weight management, female sexual health, cannabis delivery technologies and other proprietary drugs.

Callitas shares slipped a cent to hit $0.10 in New York trade on Tuesday morning.

Contact Ellen Kelleher at [email protected]

View full LILY profile View Profile

Callitas Health Inc. Timeline

Related Articles

Alliance
April 05 2019
Chief executive Peter Butterfield said the company has started 2019 well-positioned for growth after a strong performance in 2018.
Cameron Durrant
March 04 2019
A goal is to improve the safety of CAR-T therapies, used in the treatment of children with acute lymphoblastic leukemia and adults with advanced lymphomas
1537236236_main-better-use.jpg
September 17 2018
The company is utilising technology and big data to tackle the growing healthcare crisis and personalise treatment options for preventative care.
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use